Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (109)

Latest Posts

About This Stock More About This Stock
Blue Chip Stocks In Focus: Bristol-Myers Squibb
Article By: SureDividend
Monday, August 15, 2022 8:37 PM EDT
The company has grown earnings by more than 20% per year on average over the last five and ten years. This explosive growth has enabled the company to continue growing its dividend.
In this article: BMY Also: TPTX
Bristol Myers Squibb Q2 Earnings And Revenues Surpass Estimates
Article By: Zacks Investment Research
Wednesday, July 27, 2022 11:00 AM EDT
Bristol Myers Squibb came out with quarterly earnings of $1.93 per share.
In this article: BMY
Earnings Preview: Bristol Myers Squibb Q2 Earnings Expected To Decline
Article By: Zacks Investment Research
Thursday, July 21, 2022 12:20 AM EDT
Bristol Myers Squibb is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2022.
In this article: BMY
3 Blue Chip Stocks For Reliable Dividends
Article By: SureDividend
Thursday, July 14, 2022 8:18 AM EDT
Stocks that have proved resilient to recessions and offer reliable dividends, with a wide margin of safety.
In this article: BMY, STT, SWK
Bristol-Myers: "Boring Is Good"
Article By:
Monday, May 9, 2022 9:54 AM EDT
The firm’s big money-making drug, Revlimid (acquired when it bought Celgene a few years back), which treats a cancer of plasma cells called multiple myeloma, is facing increasing generic competition.
In this article: BMY

Latest Tweets for $BMY

No tweets yet!



Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

Bristol-Meyers (BMY) Head And Shoulders Pattern
Flat Broke 2/26/2020 8:46:50 PM

I fear bad news is acoming for $BMY.

Bristol-Myers To Buy Celgene; A $74 Billion Deal
Kalara J. Curtis 5/22/2019 10:47:49 AM

Nice info, thanks for sharing with us. Bullish on $BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 4 of 4 comments